MMManju Mamtani

Manju Mamtani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manju Mamtani has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early Prediction of Gestational Diabetes Using Deep Learning and Electrocardiography: Results from the MERGD Study

    by Hemant Kulkarni, Manju Mamtani, Kunal Kurhe, Ashwini Patel, Manisha Jaisinghani, Kanchan Pipal, Savita Bhargav, Prabir Kumar Das, Seema Parvekar, Vaishali Khedikar, et al.

    Background: Current guidelines by the American College of Obstetrics and Gynecology require a two-step procedure for diagnosis of gestational diabetes (GD). This two-step procedure is challenging in resource limited settings. We determined if electrocardiography (ECG) done combined with artificial intelligence techniques can predict GD to provide a non-invasive, early gatekeeper strategy for GD risk stratification. Methods: Data for this study came from the Markers of Early Risk-stratification of Gestational Diabetes (MERGD) study and included 10s, 12-lead ECGs collected at the first antenatal visit. Patients were invited to undergo GCT at 24-28 weeks and, if required, an OGTT was conducted. GCT result was considered positive if the 1-hour, 50g glucose load blood glucose level was ≥130 mg/dL. ECGs were preprocessed, filtered, and a synthetic dataset was generated by using features from autoencoders, device-reported variables and heart rate variability parameters. A random forest model (RF-ECG) was trained on the synthetic data and validated first by 10-fold cross-validation, then on a held-out test of the synthetic data and finally on the original data not seen by the model. Results: Total 1,036 quality checked, preprocessed ECGs were used in the study. A total of 123 (11.87%) women developed GD. The fully trained RF-ECG model provided validation performance as follows: 78.28% accuracy, 87.80% sensitivity, 77.00% specificity and a likelihood ratio of positive test of 3.82. The RF-ECG model outperformed existing models of GD risk stratification. Importance metric identified 40 features as contributory to the model’s diagnostic logic. Conclusions: ECGs can accurately predict the likelihood of GD ahead of the final diagnosis. If supported by external validation in future studies, our approach can help noninvasively identify GD risk early during pregnancy in resource limited settings.

  • Open Access

    A Pooled Blood Genome-Wide Association Study of Hypertension in Sindhi Families: Results from the DISFIN Study

    by Samika Kanaskar, Ashwini A. Patel, Manisha T. Jaisinghani, Kanchan V. Pipal, Mangesh Kanaskar, Manju Mamtani, Hemant Kulkarni

    Background: Hypertension is an important target for primordial prevention of complex, noncommunicable diseases, and its prevalence remains high across populations. The urban population in India is at a high risk of hypertension, but the genetic basis of hypertension in this population remains poorly understood. Methods: We conducted a pooled whole-blood genome-wide association study of 28 pools representing 1402 participants of the Diabetes In Sindhi Families In Nagpur (DISFIN) study, which enrolled families of probands with type 2 diabetes (T2D). Genotyping was done using Illumina’s Global Screening Array. Results: From a total of 608,550 single-nucleotide variants, 191 were found to be significantly associated with hypertension even after adjusting for metabolic comorbidities, batch effects, pooling error, kinship status, and pooling variation. These variants mapped to 180 well-characterized genes comprising 55 (31%) genes, and encode long noncoding RNAs (lncRNAs). Many of the genes significantly associated with hypertension (including 35% of the lncRNAs) have also been reported by other studies. However, we identified novel genes (SBF2, ARHGAP12, EPAS1, CLEC16A, and LRPPRC) to be associated with hypertension. The most significantly associated lncRNA gene was FLYWCH-AS1. Bioinformatic analyses indicated that these novel genes are likely to have functional importance in hypertension. Conclusions: Our study thus points to the potential candidate genes associated with hypertension in endogamous Sindhi families with T2D patients. The replicable and functional role of these candidate genes should be investigated in future studies.

  • Open Access

    A Pooled Blood Genome-Wide Association Study of Hypertension in Sindhi Families: Results from the DISFIN Study

    by Samika Kanaskar, Ashwini A Patel, Manisha T Jaisinghani, Kanchan V Pipal, Mangesh Kanaskar, Manju Mamtani, Hemant Kulkarni

    Hypertension is an important target for primordial prevention of complex, noncommunicable diseases and its prevalence remains high across populations. Urban population in India is at a high risk of hypertension but the genetic basis of hypertension in this population remains poorly understood. We conducted a pooled whole-blood genome-wide association study of 28 pools representing 1,402 participants of the Diabetes In Sindhi Families In Nagpur (DISFIN) study which enrolled families of probands with type 2 diabetes (T2D). Genotyping was done using Illumina’s Global Screening Array. From a total of 608,550 single nucleotide variants, 191 were found to be significantly associated with hypertension even after adjusting for metabolic comorbidities, batch effects, pooling error, kinship status and pooling variation. These variants mapped to 180 well-characterized genes that comprised 55 (31%) genes encoding long noncoding RNA (lncRNA). Many of the genes significantly associated with hypertension (including 35% of the lncRNAs) have also been reported by other studies. However, we identified novel genes (SBF2, ARHGAP12, EPAS1, CLEC16A and LRPPRC) to be associated with hypertension. The most significantly associated lncRNA gene was FLYWCH-AS1. Bioinformatic analyses indicated that these novel genes are likely to have functional importance in hypertension. Our study thus points to the potential candidate genes associated with hypertension in endogamous Sindhi families with T2D patients. The replicable and functional role of these candidate genes should be investigated in future studies.

  • Open Access

    Opportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study

    by Manju Mamtani, Kunal Kurhe, Ashwini Patel, Manisha Jaisinghani, Kanchan V. Pipal, Savita Bhargav, Shailendra Mundhada, Prabir Kumar Das, Seema Parvekar, Vaishali Khedikar, et al.

    Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RGs): GCT-negative (RG0), GCT-positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24 hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1041 pregnant women were included in the study, of whom 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD, while RG2, RG1 and RG0 comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, RG2 showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16–4.15)], any adverse outcome without [2.04 (1.17–3.55)] or with cesarean section [2.09 (1.21–3.61)] and primary cesarean section [1.68 (1.01–2.81)] after adjustment for potential confounders. RG2 was also significantly associated with pregnancy-induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.


  • Open Access

    Opportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study

    by Manju Mamtani, Kunal Kurhe, Ashwini Patel, Manisha Jaisinghani, Kanchan V Pipal, Savita Bhargav, Shailendra Mundhada, Prabir Kumar Das, Seema Parvekar, Vaishali Khedikar, et al.

    Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RG)s: GCT negative (RG0), GCT positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24-hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1,041 pregnant women were included in the study of who 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD while the RG2, RG1 and RG0 groups comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, the RG2 group showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16-4.15)], any adverse outcome without [2.04 (1.17-3.55)] or with cesarean section [2.09 (1.21-3.61)], and primary cesarean section [1.68 (1.01-2.81)] after adjustment for potential confounders. The RG2 group was also significantly associated with pregnancy induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.

  • Open Access

    Machine-learning algorithm to non-invasively detect diabetes and pre-diabetes from electrocardiogram

    by Anoop R Kulkarni, Ashwini A Patel, Kanchan V Pipal, Sujeet G Jaiswal, Manisha T Jaisinghani, Vidya Thulkar, Lumbini Gajbhiye, Preeti Gondane, Archana B Patel, Manju Mamtani, et al.

    Objectives Early detection is of crucial importance for prevention of type 2 diabetes and pre-diabetes. Diagnosis of these conditions relies on the oral glucose tolerance test and haemoglobin A1c estimation which are invasive and challenging for large-scale screening. We aimed to combine the non-invasive nature of ECG with the power of machine learning to detect diabetes and pre-diabetes. Methods Data for this study come from Diabetes in Sindhi Families in Nagpur study of ethnically endogenous Sindhi population from central India. Final dataset included clinical data from 1262 individuals and 10 461 time-aligned heartbeats recorded digitally. The dataset was split into a training set, a validation set and independent test set (8892, 523 and 1046 beats, respectively). The ECG recordings were processed with median filtering, band-pass filtering and standard scaling. Minority oversampling was undertaken to balance the training dataset before initiation of training. Extreme gradient boosting (XGBoost) was used to train the classifier that used the signal-processed ECG as input and predicted the membership to ‘no diabetes’, pre-diabetes or type 2 diabetes classes (defined according to American Diabetes Association criteria). Results Prevalence of type 2 diabetes and pre-diabetes was ~30% and ~14%, respectively. Training was smooth and quick (convergence achieved within 40 epochs). In the independent test set, the DiaBeats algorithm predicted the classes with 97.1% precision, 96.2% recall, 96.8% accuracy and 96.6% F1 score. The calibrated model had a low calibration error (0.06). The feature importance maps indicated that leads III, augmented Vector Left (aVL), V4, V5 and V6 were most contributory to the classification performance. The predictions matched the clinical expectations based on the biological mechanisms of cardiac involvement in diabetes. Conclusions Machine-learning-based DiaBeats algorithm using ECG signal data accurately predicted diabetes-related classes. This algorithm can help in early detection of diabetes and pre-diabetes after robust validation in external datasets.


  • Open Access

    Susceptibility Loci for Type 2 Diabetes in the Ethnically Endogamous Indian Sindhi Population: A Pooled Blood Genome-Wide Association Study

    by Kanchan V. Pipal, Manju Mamtani, Ashwini A. Patel, Sujeet G. Jaiswal, Manisha T. Jaisinghani, Hemant Kulkarni

    Type 2 diabetes (T2D) is a complex metabolic derangement that has a strong genetic basis. There is substantial population-specificity in the association of genetic variants with T2D. The Indian urban Sindhi population is at a high risk of T2D. The genetic basis of T2D in this population is unknown. We interrogated 28 pooled whole blood genomes of 1402 participants from the Diabetes In Sindhi Families In Nagpur (DISFIN) study using Illumina’s Global Screening Array. From a total of 608,550 biallelic variants, 140 were significantly associated with T2D after adjusting for comorbidities, batch effects, pooling error, kinship status and pooling variation in a random effects multivariable logistic regression framework. Of the 102 well-characterized genes that these variants mapped onto, 70 genes have been previously reported to be associated with T2D to varying degrees with known functional relevance. Excluding open reading frames, intergenic non-coding elements and pseudogenes, our study identified 22 novel candidate genes in the Sindhi population studied. Our study thus points to the potential, interesting candidate genes associated with T2D in an ethnically endogamous population. These candidate genes need to be fully investigated in future studies.


  • Open Access

    Genetic association of anthropometric traits with type 2 diabetes in ethnically endogamous Sindhi families

    by Manju Mamtani, Manisha T. Jaisinghani, Sujeet G. Jaiswal, Kanchan V. Pipal, Ashwini A. Patel, Hemant Kulkarni

    Background: Ethnically endogamous populations can shed light on the genetics of type 2 diabetes. Such studies are lacking in India. We conducted this study to determine the genetic and environmental contributions of anthropometric traits to type 2 diabetes risk in the Sindhi families in central India. Methods: We conducted a family study in Indian Sindhi families with at least one case of type 2 diabetes. Variance components methods were used to quantify the genetic association of 18 anthropometric traits with eight type 2 diabetes related traits. Univariate and bivariate polygenic models were used to determine the heritability, genetic and environmental correlation of anthropometric traits with type 2 diabetes related traits. Results: We included 1,152 individuals from 112 phenotyped families. The ascertainment-bias corrected prevalence of type 2 diabetes was 35%. Waist circumference, hip circumference and the biceps, triceps, subscapular and medial calf skinfold thicknesses were polygenically and significantly associated with type 2 diabetes. The range of heritability of the anthropometric traits and type 2 diabetes related traits was 0.27–0.73 and 0.00–0.39, respectively. Heritability of type 2 diabetes as a discrete trait was 0.35. Heritability curves demonstrated a substantial local influence of type 2 diabetes related traits. Bivariate trait analyses showed that biceps and abdominal skinfold thickness and all waist-containing indexes were strongly genetically correlated with type 2 diabetes. Conclusions: In this first study of Sindhi families, we found evidence for genetic and environmental concordance of anthropometric traits with type 2 diabetes. Future studies need to probe into the genetics of type 2 diabetes in this population.


  • Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study

    by M. Mamtani, A.M. Athavale, M. Abraham, J. Vernik, A.R. Amarah, J.P. Ruiz, A.J. Joshi, M. Itteera, S.D. Zhukovski, R.P. Madaiah, et al.


  • Open Access

    ASSOCIATION OF HYPERGLYCEMIA WITH HOSPITAL MORTALITY IN COVID-19 PATIENTS WITHOUT DIABETES: A COHORT STUDY

    by Manju Mamtani, Ambarish M. Athavale, Mohan Abraham, Jane Vernik, Amatur R Amarah, Juan P. Ruiz, Amit J. Joshi, Matthew Itteera, Sara D Zhukovski, Ravi Prakash Madaiah, et al.

    Objective: Diabetes is a known risk factor for mortality in Coronavirus disease 2019 (COVID-19) patients. Our objective was to identify prevalence of hyperglycemia in COVID-19 patients with and without diabetes and quantify its association with COVID-19 disease course. Research Design and Methods: In this observational cohort study, all consecutive COVID-19 patients admitted to John H Stroger Jr. Hospital, Chicago, IL from March 15, 2020 to May 15, 2020 were included. The primary outcome was hospital mortality and the main predictor was hyperglycemia (any blood glucose ≥7.78 mmol/L during hospitalization). Results: Of 403 COVID-19 patients studied, 228 (57%) developed hyperglycemia. Of these, 83 (21%) had hyperglycemia without diabetes. A total of 51 (12.7%) patients died. Compared to the reference group no-diabetes/no-hyperglycemia patients the no-diabetes/hyperglycemia patients showed higher mortality (1.8% versus 20.5%, adjusted odds ratio 21.94 (95% confidence interval 4.04-119.0), p < 0.001); improved prediction of death (p=0.0162) and faster progression to death (p=0.0051). Hyperglycemia within the first 24 and 48 hours was also significantly associated with mortality (odds ratio 2.15 and 3.31, respectively). Further, compared to the same reference group, no-diabetes/hyperglycemia patients had higher risk of ICU admission (p<0.001), mechanical ventilation (p<0.001) and acute respiratory distress syndrome (p<0.001) and a longer hospital stay in survivors (p<0.001). Conclusions: Hyperglycemia in the absence of diabetes was common (21% of hospitalized COVID-19 patients) and was associated with an increased risk of and faster progression to death. Development of hyperglycemia in COVID-19 patients who do not have diabetes is an early indicator of poor prognosis.